What Happens If I Use Marijuana With Heart Disease?

Cardio Renal Foundation is a 501(c)(3) tax-exempt charity organization. Your donation advances our mission to provide a solution beyond dialysis.

The plain question: can I use marijuana, with this heart? Here the first-breath answer comes from the American Heart Association itself, and it is more pointed than most people expect. In its 2020 scientific statement on cannabis and cardiovascular health, the AHA found no well-documented benefit of cannabis for preventing or treating cardiovascular disease, recommended that people not smoke or vape any substance — cannabis products included — and warned that for people already diagnosed with heart disease, cannabis should be used with extreme caution, because it increases the heart's need for oxygen at the same time as it decreases the oxygen supply. What follows is what the use does, and when it does it.

The First Hour: More Demand, Less Supply

Smoked marijuana acts fast, and its first cardiovascular acts are mechanical. Heart rate rises in a dose-dependent fashion; blood pressure rises while lying down and can drop on standing, which is the pharmacology behind the dizziness new users report. The heart is, in other words, being asked to beat faster and harder. For a healthy young heart that is a curiosity. For a heart fed by narrowed arteries, the AHA's framing is the whole story in one line: demand up, supply down — the exact setup for angina, chest pain from a heart outrunning its blood supply. These effects begin within minutes of smoking and are strongest in the first hour or two, which is why the next chapter is measured in hours rather than years.

The Trigger Window: Heart Attacks Timed to the Hour

The most precise evidence in this field comes from a study designed to catch triggers in the act. In the Determinants of Myocardial Infarction Onset Study, published in Circulation in 2001, researchers interviewed 3,882 heart-attack patients about the hours before their symptoms. The risk of a heart attack beginning was elevated 4.8 times over baseline in the sixty minutes after smoking marijuana, fell to 1.7 times in the second hour, and returned to baseline after that. The authors' own adjective was rare — marijuana is a rare trigger, because most users are young, with clean arteries. But read the conclusion from this page's chair: the trigger multiplies whatever risk is already sitting in the arteries, and a reader with diagnosed heart disease is carrying exactly the substrate a trigger needs. If you want the rhythm side of that first hour explained, our page on what an abnormal EKG means is the companion.

Rhythm, Muscle, and Stroke: The Observational Ledger

Beyond the first hour, the AHA statement assembles what observational studies — following users and non-users over time, without assigning the drug — have found: the chemicals in cannabis linked to increased risk of heart attacks, heart failure, and atrial fibrillation, and smoking or inhaling cannabis associated with cardiomyopathy (heart muscle dysfunction), angina, heart rhythm disturbances, and sudden cardiac death. In one large study of American adults reported at an AHA scientific meeting, daily marijuana use was linked to about a one-third higher risk of developing heart failure. Two honest caveats belong in the same breath. Observational links are not proof of cause, and cannabis research has been throttled for decades by the drug's federal Schedule I status — the AHA statement itself calls urgently for better studies. But unproven is not the same as reassuring, and the signals point one way. For readers whose diagnosis is heart failure, the practical guidance from cardiology is to avoid cannabis — a weakened pump has no surplus for a drug that raises its workload while trimming its oxygen. Our page on how long people live with heart failure and kidney disease covers the ground that risk lands on.

Smoked, Vaped, or Eaten: The Route Changes the Risk, Not the Direction

The AHA statement is bluntest about smoke, with numbers worth knowing: smoking and inhaling cannabis, whatever its THC content, was associated with a fivefold increase in blood carbon monoxide concentrations and about a threefold increase in tar — territory comparable to tobacco smoke, which is why the recommendation covers vaping too. Edibles remove the combustion and keep everything else: the same THC reaches the same heart, with two practical traps of its own. An edible's effects arrive slowly — an hour or more is common — so people take a second dose before the first has landed, and the combined dose arrives all at once. And edible strength varies enormously from product to product, so the dose a label promises and the dose a body gets are not always the same number. Nothing on this page is a guide to using any of it, by any route; the point is narrower — changing the route trades one set of hazards for another. It does not leave the heart out of it.

Synthetics Are Not Marijuana

One category must not ride under this page's title. Synthetic marijuana — K2, spice, and their relatives — is not the plant; it is laboratory-made chemicals sprayed onto plant material, far stronger at the same receptors, unpredictable from package to package, and associated with racing hearts, severe agitation, and organ injury. The kidney chapter of that story is documented by the CDC and told in full in our companion page: what happens if I use marijuana with kidney disease? For a heart reader the rule is simple: whatever judgment you reach about cannabis itself, the synthetics are a different and worse bet.

Why This Research Matters

Step back and notice what this page is really describing: a substance marketed in the language of relaxation that begins, physiologically, by making a damaged heart work harder on less oxygen — and a research record kept thin by law precisely where patients need it thick. The Cardio Renal Foundation supports research toward a solution beyond dialysis — research aimed at understanding what everyday substances ask of a heart and kidneys already working at their limit, and at protecting both organs before strain becomes damage. That is a direction, not a promise — but it is aimed squarely at the burden this page describes.

So — what happens if you use marijuana with heart disease? In the first hour, a faster heart demanding more oxygen through arteries that may not be able to deliver it, and a measurably multiplied chance that a vulnerable artery declares itself. Over years, an observational ledger of rhythm trouble, muscle damage, failure, and stroke that no major heart body reads as reassuring. The AHA's summary needs no improvement: no proven benefit for the heart, real documented hazards, and for the already-diagnosed, extreme caution at best. Your cardiology team should hear about any use — not to scold, but because they are managing the exact machinery this drug leans on.

At the Cardio Renal Foundation (Cardio Renal Foundation Inc, EIN 33-4359765), we publish education for exactly this reader — a heart on the problem list and a question nobody at the clinic visit quite asked, decided on evidence instead of rumor. Support from readers like you helps us keep publishing it.

This article is informational only and is not meant to replace the advice of your qualified healthcare provider. Nothing here diagnoses any condition or recommends any treatment. Never start, stop, skip, or change the dose of a prescribed medicine without speaking to the clinician who prescribed it. Chest pain or pressure, fainting, or a racing or irregular heartbeat after using marijuana can signal a heart emergency: call 911. Research supported by this Foundation is investigational only. As with any issues related to your health, check with your doctor.